Tariffs and Life Sciences Supply Chain
When supply chains stall and regulatory winds shift, do your operations bend - or break?
We help life sciences companies gain a competitive advantage amid volatility. Our consulting expertise enables companies to develop best-of-breed facility qualification, operational resilience, and sourcing strategies. Our solutions are tailored, targeted, and practical - especially in situations that demand speed, precision, and regulatory compliance.
The stakes are real - and rising
The global pipeline is fragile, covering everything from saline drips to GLP-1 therapies. Tariff shifts, regulatory ambiguity, and sourcing bottlenecks can slow operations down, but standing still is not a strategy.
What’s shifting
The disruptions haven’t slowed, but how companies respond is starting to change. We’re seeing less reliance on rigid playbooks and more openness to practical, sometimes unconventional solutions. Speed matters, but so does regulatory confidence. Teams want options they can defend, not just move on. That’s the space we operate in: helping organizations act decisively without overextending their risk tolerance.
NSF delivers resilience where it matters most
Operational readiness: Build facilities that launch faster
Facility qualification and commissioning
We lead qualification efforts that meet global expectations, reducing startup delays and regulatory friction.
Production qualification
We validate production processes end-to-end for drugs, biologics, and devices - so you can scale with confidence.
Sourcing resilience: Rethink the way you source
Supply chain engineering
Redesign global sourcing models to resist tariffs, IP restrictions, and compliance traps.
LATAM market entry
Navigate registration and facility readiness to unlock new sourcing geographies.
Compounding and direct alternatives
We help you source around the bottlenecks - with compliant, creative workarounds.
Regulatory access: Stay aligned across borders
Facility registration and re-registration
Maintain uninterrupted approvals with full-service global registration support.
Post-market service programs
For medical devices, we build compliant US repair/service models to meet FDA and customer needs.
Tariff intelligence and sourcing strategy
Get ahead of policy changes with real-time insights and proactive sourcing planning.
Progress under pressure
For many life sciences companies, operational strategy used to mean long-term planning, stable sourcing, linear launches, and predictable approvals. That model doesn’t hold up anymore. Teams now have to build flexibility into the core of their processes, not just as a backup plan. Whether it’s navigating tariffs, rethinking registration timelines, or adjusting sourcing routes on short notice, the challenge isn’t just technical - it’s organizational. We work with companies to adapt faster, without losing sight of compliance or long-term goals.
Why leading life sciences companies trust us
• End-to-end expertise: From facility buildout to sourcing resilience
• Global reach, local insight: We operate in 50+ markets with regional knowledge
• Deep regulatory fluency: Across FDA, EU GMP, ANVISA, and more
• Confidential, tailored support: Hands-on, high impact, always focused on your outcomes
Resources
How the QA and QP Talent Market Is Changing in Pharma: Insights from Compliance Unlocked Podcast
PodcastRecruiting and retaining experienced quality and regulatory professionals has become significantly more complex for pharmaceutical and biotech companies.
The Foundations of Pharmaceutical Compliance for Beginners
ArticleWhether you’re stepping into the pharmaceutical industry for the first time or pivoting into a compliance or quality assurance role after years of experience, mastering the fundamentals of quality and regulatory compliance is vital to your success—and to the success of your organization.
Challenges at the Intersection of Medical Device Software and Machine Learning
ArticleMedical device manufacturers increasingly incorporate machine learning (ML) models into their products, significantly enhancing their capabilities. However, integrating ML into the established processes of medical device development introduces challenges due to fundamental differences between traditional software development and ML model development.